Story

The Full Story

IMCV is a passively managed iShares index ETF, so its "story" is not one of CEO pivots or guidance misses — it is the story of one explicit promise (track the index, cheaply) kept across two decades, one quiet but consequential index methodology swap in March 2021, and a steady drift in what its sector exposure actually is. The fund's narrative shifted decisively between FY2021 and FY2022: the expense ratio was cut from 0.27% to 0.06%, the underlying index was rebadged from the "Morningstar US Mid Value Index" to the broader "US Mid Cap Broad Value Index," and AUM has more than 50% in the eighteen months since (from ~$643M at Apr-2025 to ~$975M at Mar-2026). Tracking accuracy versus the stated benchmark has been near-perfect across CY2021–CY2025, but the longer 10-year benchmark gap (Fund 8.04% vs benchmark 8.23%) reveals the cost of pre-2021 expense drag. Credibility is high because the only thing management actually promised — index fidelity at low cost — has been delivered; the legitimate critique is that what "mid-cap value" means inside the fund has shifted under the reader's feet.

1. The Narrative Arc

The single most important moment in this fund's life is March 22, 2021, when the benchmark switched from the narrower "US Mid Value Index" to the broader "US Mid Cap Broad Value Index." Performance attribution is split before and after that date in every official document — a quiet acknowledgement that pre-2021 returns and post-2021 returns are not strictly comparable. The fee cut from 27 bps to 6 bps that landed alongside it transformed IMCV from a higher-fee niche product into a cost-competitive cornerstone vehicle — and it is the reason AUM is now compounding visibly.

2. What Management Emphasized — and Then Stopped Emphasizing

BlackRock writes a fresh "Portfolio Management Commentary" each year about which sectors drove returns. The themes rotate with the market — but a few phrases repeat, and a few quietly drop.

Three honest pivots show up clearly:

• Industrials & CHIPS-Act capex was a headline driver in FY2024 and is gone from FY2025 commentary even though the sector still represents 8.6% of holdings.
• AI went from a single mention as an end-market for tech hardware in FY2024 to the primary attribution variable in FY2025 — but framed as power demand for utilities, not as a tech story.
• Decarbonisation / energy transition, a recurring talking point in the FY2024 shareholder letter, is absent from the FY2025 tailored shareholder report. The disclosure format change shrank room for editorial themes; the dropped vocabulary is partly format-driven, partly substantive.

The FY2025 disclosure was reformatted to the SEC's "Tailored Shareholder Report" template, which mechanically shortened narrative — so some "drops" reflect a format constraint, not a deliberate de-emphasis. Where it does matter is in what BlackRock chose to spend its now-shorter word count on: AI-driven utility demand and trade-war pressure on biotech, not the prior year's CHIPS / industrials story.

3. Risk Evolution

The substantive change in the FY2025 prospectus is the consolidation of a standalone "Cybersecurity Risk" factor into a broader "Operational and Technology Risks" disclosure that for the first time names artificial intelligence and machine learning as a source of operational risk for the fund's service providers and the issuers it holds. The standalone "Industrial Companies Risk" was dropped — likely because industrials slipped from 11.7% to 8.6% of the portfolio between FY2024 and FY2025 and no longer met BlackRock's internal threshold for a dedicated factor. The "Index-Related Risk" wording was tightened to add a phrase about index errors potentially impacting the fund's ability "to meet its investment objective" — a small but legally meaningful upgrade.

What is not in the risk factors and arguably should be discussed: the 10-year benchmark gap (see §5) and the structural concentration in financials, which has crept from 17.7% to 18.4% to 19.3% in eighteen months without a corresponding new risk factor.

4. How They Handled "Bad News"

For an index ETF the only "bad news" available is (a) tracking the benchmark imperfectly and (b) the asset class itself underperforming a broader reference. FY2025 produced a small example of (b).

In FY2025 the fund returned 5.39% while the broad Morningstar US Market Index returned 11.51% — a 612-bps shortfall driven entirely by the value style being out of favor relative to the broader market, not by the fund missing its index. BlackRock's response was procedural rather than apologetic: it added the broad market index to the disclosure "in response to new regulatory requirements." The phrasing is honest — the fund did what it was designed to do — but it surfaces a structural issue for investors who may not have appreciated how much value-style positioning costs in a market where mega-cap growth dominates.

The way the FY2025 shareholder report explains the underperformance is also notable for what it does not say. It cites trade-war pressure on biotech and weak chemicals as detractors, but does not discuss the larger truth: mid-cap value as a category trailed the U.S. market by ~6 percentage points. This is straight description without spin — but also without the larger framing.

5. "Guidance" Track Record — Tracking Error

The only enforceable promise IMCV makes is to deliver the underlying index's return, after fees. We measure the promise as tracking difference (Fund NAV return minus benchmark return) by calendar year.

Score: 9 / 10. Year-by-year tracking has been within 15 bps for five straight calendar years — a textbook execution outcome. The only thing keeping this from a 10 is the long-horizon picture: the 10-year and since-inception annualized gaps (-16 bps and -23 bps) are wider than the post-fee-cut 6 bps expense ratio would imply, because they include the high-fee 0.27% era and the 2021 index methodology reset. Anyone benchmarking IMCV against the current index methodology and current expense ratio should expect ~6–10 bps of annual drag, and that is what the post-2021 data show.

6. What the Story Is Now

What you are buying today is no longer quite what you were buying three years ago. Energy weight has nearly doubled (6.1% → 10.0%) since FY2024, financials concentration has crept up to 19.3%, and real estate has been cut by a quarter (8.0% → 6.0%). These are not BlackRock decisions — they are Morningstar's index methodology working as designed against a changing universe — but they are the substantive change in what the fund actually holds.

The story today is simpler and cleaner than it was pre-2021: a low-cost, high-fidelity vehicle for U.S. mid-cap value exposure, run on a broad and transparent index, with no hidden manager bets. The legitimate concern is not credibility — it is positioning. Whoever owns IMCV is making a deliberate factor bet; the fund will deliver that bet faithfully, including in years when it stings.